Ho. Pae et al., ENHANCING AND PRIMING OF MACROPHAGES FOR SUPEROXIDE ANION PRODUCTION BY TAXOL, Immunopharmacology and immunotoxicology, 20(1), 1998, pp. 27-37
Taxol, an anticancer drug, has been known not only to block cell divis
ion by stabilizing microtubules but also to activate murine macrophage
s to express TNF-alpha, interleukin-l, and to produce nitric oxide (NO
). We therefore reasoned that taxol could activate murine macrophages
to generate reactive oxygen intermediates, such as superoxide anion (O
-2(-)), which are responsible for intracellular killing of pathogenic
microbes. Treatment of RAW264.7 cells, murine macrophage cell line, wi
th taxol increased phorbol ester-induced O-2(-) production in a dose d
ependent manner (similar to 2 fold). In addition, taxol rapidly (<1 hr
) primed RAW264.7 cells to enhance O-2(-) release stimulated with PMA.
Taxol also enhanced stimulation of O-2(-) production by FMLP, but not
by Con A. This effect was abolished by prior treatment with both supe
roxide dismutase (SOD) and N-acetyl-L-cystein, a free radical scavenge
r. To investigate the mechanism of taxol-induced macrophage stimulatio
n, we evaluated the ability of colchicine, a drug that inhibit tubulin
polymerization, and cAMP analogues, which is known to depolymerize mi
crotubule. Taxol-induced O-2(-) production was inhibited by the treatm
ent with both colchicine and DB-cAMP. Taken together, these results de
monstrated that taxol provides two signals, ''priming'' and ''enhancin
g'', to generate superoxide anion via the stabilization of microtubule
s in murine RAW264.7 cells.